Alex Herrera, M.D., clinical and research interests center on immunotherapy and hematopoietic stem cell transplantation in patients with lymphoma. He is the principal investigator of over 30 clinical trials evaluating novel agents for the treatment of Hodgkin or non-Hodgkin lymphomas, including 12 investigator-initiated trials. He also studies biomarkers of response and outcome in patients with lymphoma treated with immunotherapies or hematopoietic stem cell transplantation with the goal of designing biomarker-based clinical trials to improve outcomes and personalize lymphoma treatment.